A5080603592- Hepatocellular Carcinoma Treatment and Prognosis
- Tuberous Sclerosis Complex Research
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Endometrial and Cervical Cancer Treatments
- Breast Cancer Treatment Studies
- Cancer Treatment and Pharmacology
- Mast cells and histamine
- Renal and related cancers
- Gynecological conditions and treatments
- Eosinophilic Disorders and Syndromes
- Cancer Immunotherapy and Biomarkers
- Gastrointestinal Tumor Research and Treatment
- Reproductive System and Pregnancy
- Cancer Research and Treatments
- Cancer Genomics and Diagnostics
- Advanced Breast Cancer Therapies
- Breast Lesions and Carcinomas
- Economic and Financial Impacts of Cancer
- Lung Cancer Treatments and Mutations
- Vascular Tumors and Angiosarcomas
- Renal cell carcinoma treatment
- MXene and MAX Phase Materials
- Lung Cancer Research Studies
Bellvitge University Hospital
2024
Institut d'Investigació Biomédica de Bellvitge
2013-2023
Institut Català d'Oncologia
2015-2023
Introduction: Neoadjuvant chemotherapy in breast cancer offers the possibility to facilitate and axillary surgery; it is a test of chemosensibility vivo with significant prognostic value may be used tailor adjuvant treatment according response. Material Methods: A retrospective single-institution cohort 482 stage II III patients treated neoadjuvant based on anthracycline taxans, plus antiHEr2 Her2-positive cases, was studied. Survival calculated at 5 10 years. Kaplan–Meier curves log-rank...
Lymphangioleiomyomatosis (LAM) is a rare lung-metastasizing neoplasm caused by the proliferation of smooth muscle-like cells that commonly carry loss-of-function mutations in either tuberous sclerosis complex 1 or 2 (TSC1 TSC2) genes. While allosteric inhibition mechanistic target rapamycin (mTOR) has shown substantial clinical benefit, complementary therapies are required to improve response and/or treat specific patients. However, there lack LAM biomarkers could potentially be used monitor...
Rapid and reliable diagnosis of endometrial cancer (EC) in uterine aspirates is highly desirable. Current sensitivity failure rate histological limit the success this method subsequent hysteroscopy often necessary. Using quantitative reverse transcriptase-polymerase chain reaction on RNA from samples, we measured expression level 20 previously identified genes involved EC pathology, created five algorithms based combinations evaluated their ability to diagnose EC. The were tested a...
Molecular evidence has linked the pathophysiology of lymphangioleiomyomatosis (LAM) to that metastatic breast cancer. Following on this observation, we assessed association between LAM and subsequent An epidemiological study was carried out using three country cohorts, from Japan, Spain, United Kingdom. The number incident cancer cases observed in these cohorts compared with expected basis country-specific incidence rates for period 2000–2014. Immunohistochemical studies exome sequence...